Human CD34<sup>+</sup>-derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy.

Front Immunol · 2024 · PMC11578708 · PMID 39575246

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Co-cultures with TLR7-treated CB-pDCs showed a trend towards enrichment of the cytotoxic mediators granzyme A, granulysin, and soluble FAS whereas untreated CB-pDCs in the co-cultures induced stronger granzyme B and perforin secretion.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.